Countries for treatment Targeted therapy in Austria Targeted therapy in Azerbaijan Targeted therapy in China Targeted therapy in Germany Targeted therapy in India Targeted therapy in Israel Targeted therapy in Italy Targeted therapy in Republic of Korea ...
A targeted therapy is one that has been developed to affect a specific target, such as an enzyme or receptor. Targeted therapies can either block or increase the function of their target in order to treat a given disease; in this case, cancer. ...
A molecularly targeted therapy is designed to specifically modulate the function of a protein or other cellular component linked to a particular disease; for example, specific inhibitors of protein kinase involved in cell proliferation are used to treat some cancers. Such therapies may often be used...
The high burden of cancers is the key driving factor for the growth of the targeted cancer therapy market. For instance, as per the study report published by the Indian Journal of Medical Research in December 2022, the number of new cancer cases in India is estimated to be 14,61,427 case...
Our 3D Prostate Precision & Targeted Therapy is an advanced non-surgical, non-radiotherapy, non-chemotherapy, non-hormone, and very safe treatment without any side effects. Our treatment method can completely treat prostate cancer, prostatitis, enlarged
for providing temporary protection against a microbial agent. Commonly, antibody therapy is faster than vaccines in emergency situations (Graham and Ambrosino2015). Until now, several antibodies have been approved to treat a number of diseases such as some types of cancer and autoimmune disorders (...
One key trend in the Cell Penetrating Peptide Market is the rising adoption of cell-penetrating peptides in cancer therapy, as these peptides have shown promising results in delivering anti-cancer drugs directly to tumor cells. Another trend is the increasing research and development activities in ...
For instance, the specific therapeutic regimens using anthracyclines and taxanes as adjuvant therapy for breast cancer, regimes for hematological malignancies, including acute lymphoblastic leukemia, targeted therapeutics such as, imatinib, to specifically inhibit oncogenic signalling cascades in chronic myeloid...
The application of nanomedicines is increasing rapidly with the promise of targeted and efficient drug delivery. Nanomedicines address the shortcomings of conventional therapy, as evidenced by several preclinical and clinical investigations indicating si
Cancer, a complex and multifactorial disease, presents a significant challenge to global health. Despite significant advances in surgical, radiotherapeutic and immunological approaches, which have improved cancer treatment outcomes, drug therapy continue